Cargando…
Cyclin D1 and PRAME expression in distinguishing melanoma in situ from benign melanocytic proliferation of the nail unit
BACKGROUND: Distinguishing benign lesion from early malignancy in melanocytic lesions of the nail unit still remains a diagnostic challenge, both clinically and histopathologically. While several immunohistochemistry (IHC) stainings have been suggested to help discriminate benign subungual melanocyt...
Autores principales: | Kim, Young Jae, Jung, Chang Jin, Na, Hyoungmin, Lee, Woo Jin, Chang, Sung Eun, Lee, Mi Woo, Park, Chan-Sik, Lim, Youngkyoung, Won, Chong Hyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9047257/ https://www.ncbi.nlm.nih.gov/pubmed/35484605 http://dx.doi.org/10.1186/s13000-022-01218-3 |
Ejemplares similares
-
Editorial Comment on “Performance of PRAME immunohistochemistry compared with that of c‐Kit, c‐Myc, or cyclin D1 for the diagnosis of acral melanocytic tumors”
por: Izumi, Miki
Publicado: (2022) -
HMB45/PRAME, a Novel Double Staining for the Diagnosis of Melanocytic Neoplasms: Technical Aspects, Results, and Comparison With Other Commercially Available Staining (PRAME and Melan A/PRAME)
por: Grillini, Marco, et al.
Publicado: (2022) -
Eruptive Benign Melanocytic Nevi Formation Following Adalimumab Therapy in a Patient with Crohn's Disease
por: Moon, Ik Jun, et al.
Publicado: (2016) -
PRAME Immunoexpression in 275 Cutaneous Melanocytic Lesions: A Double Institutional Experience
por: Cazzato, Gerardo, et al.
Publicado: (2022) -
PRAME expression is similar in scar and desmoplastic melanoma
por: Plotzke, Jaclyn M., et al.
Publicado: (2022)